2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Abstract Author

 

Edward G McFarland, MD, FAAOS

Johns Hopkins University School of Medicine
Baltimore, Maryland UNITED STATES

Mon 06/09
16:40 - 16:45
Room 11 Afternoon Scientific Session II
Paper
Outcomes Of Reverse Total Shoulder Arthroplasty In Patients Aged 50 And Younger
Author
ePosters
Sports Medicine
E-Poster
Impact Of Semaglutide Versus Non-Glp-1 Agonists In Patients With Significant Adiposity Or Type 2 Diabetes Mellitus On The Incidence Of Osteoarthritis And Total Joint Arthroplasty
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Glenoid Component Removal Methods In Revision Reverse Total Shoulder Arthroplasty
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Effect Of Insulin Dependence On Complications Following Total Shoulder Arthroplasty In Patients With Diabetes Mellitus
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Risk Factors Associated With 30-Day Inpatient Mortality After Shoulder Arthroplasty
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Opioid Prescriptions Following Total Shoulder Arthroplasty Is Associated With New Persistent Opioid Use: A Retrospective Cohort Study
Author
ePosters
Shoulder - Other
E-Poster
Effects Of Corticosteroid Injection For Adhesive Capsulitis With Type 2 Diabetes Mellitus: A Comparative Study
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Preoperative Weight Loss Before Total Shoulder Arthroplasty Does Not Impact Postoperative Outcomes
Author
ePosters
Shoulder - Arthroplasty
E-Poster
Data-Driven Threshold For Timing Of Dislocation Associated With Increased Risk Of Revision Following Total Shoulder Arthroplasty
Author

Disclosures

Royalties received from Innomed
Speaker for Stryker
Paid Consultant for DePuy, A Johnson & Johnson Company, StrykerDePuy-Mitek
Financial Support received from Arthrex, Inc, ASES, DePuy, A Johnson & Johnson Company, OMEGA, Smith & Nephew, Wright Medical Technology, Inc.
Editorial or Governing board of American Journal of Sports Medicine, Clinical Orthopaedics and Related Research

All relevant financial disclosures have been mitigated.